Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

Effective treatments for severe alopecia areata are still lacking.

Researchers identified a new hair loss pattern called "sisaipho type," where hair is lost across the scalp except around the edges.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Low-dose methotrexate effectively regrows hair in many alopecia areata patients but can cause some side effects.

Methylprednisolone infusions can help some people with severe alopecia regrow hair.

Horse alopecia areata is rare and mainly affects their appearance.

Some people with severe, long-lasting baldness responded well to a specific combination treatment.

The cause of alopecia areata was unknown, and while various treatments existed, no best treatment was agreed upon.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

Alopecia areata and androgenetic alopecia affect quality of life similarly.

Patchy alopecia areata can affect only pigmented hairs, leaving gray hairs untouched.

Clobetasol and pimecrolimus are similarly effective for alopecia areata, but pimecrolimus has fewer side effects and is preferred for long-term use.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Leflunomide and anthralin may effectively treat severe alopecia areata.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

Greying hairs may be protected from alopecia areata.

Alopecia areata greatly affects people's life quality, mental health, and work life.

Treating alopecia areata every 3 weeks with diphenylcyclopropenone is more effective than weekly treatments.

Higher DKK-1 levels found in hair loss patients; L-ascorbic acid 2-phosphate, L-threonate, and ginsenoside F2 may help promote hair growth.

Understanding alopecia areata's patterns can improve future research and treatments.

The author clarified that Alopecia Areata Incognita (AAI) and diffuse Alopecia Areata (AA) are different conditions and the case discussed was actually AA, not AAI.

c-kit affects hair growth and color in alopecia areata and androgenetic alopecia.

DKK-1 gene linked to hair loss in AGA and AA patients; more research needed for potential therapy.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

Alopecia areata impacts mental well-being more due to perceptions and stigma than disease severity.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

PRP works faster and is a safe alternative to steroids for treating alopecia areata.

A man's scalp condition was misidentified as hair loss dots but was actually a common follicular disorder.